When choosing an Intraosseous Infusion device, there are five important factors that every emergency medical services and healthcare provider should consider:
Intraosseous fluids ‘have great promise for reducing the mortality of Ebola virus…’ according to World Health Organization Doctor.Intraosseous Infusion | 0 Comments
A recent October 10, 2014 article, “Experts Closest to Ebola Outbreak Testify” written by Daniel M. Keller, PhD, discusses the importance of supportive care and rehydration in treating the Ebola virus.
In the article, Robert Fowler, MD, from the World Health Organization (WHO) Department of Pandemic and Epidemic Disease explains, “Rehydration is a real key to management, beginning with oral rehydration, ‘but there comes a time very quickly, 4 or 5 days in, where people can no longer drink,’ he explained. At that point, intravenous or intraosseous fluids "have great promise for reducing the mortality of Ebola virus disease generally, even without specific medications."
Intraosseous Infusion Series - Post #1 – by Dr. Alan Moloff
This is the first post in our Intraosseous (IO) Infusion Series. In this series, Pyng’s Chief Medical Officer, Dr. Alan Moloff, will explore the history, usage and indications for IO, and will specifically examine the emergence of Sternal IO and why it is a preferred choice for intravenous access by military, special forces, EMS and critical care personnel.
In a September 5, 2014 Huffington Post article, Into Africa to Fight Ebola, writer Claire Fordham highlights the work of Dr. Suzanne Donavon, a volunteer with the World Health Organization who travelled to Sierra Leone to help fight the Ebola outbreak